Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Regulatory

'Not FDA Approved' — What It Actually Means for Compounded GLP-1s

Not approved means not premarket-reviewed. It's a real distinction, not a scare word.

"Compounded medications are not FDA approved" appears on every legitimate compounded GLP-1 page, including this one. This piece explains exactly what that phrase means, what it doesn't mean, and why it isn't the same as calling a product "unsafe."

What "not FDA approved" actually means

It means the specific product did not go through FDA's premarket review — the process where FDA evaluates a drug's manufacturing, safety, and effectiveness before it can be marketed. Approved products like Wegovy, Ozempic, and Zepbound went through that review; compounded semaglutide and tirzepatide did not. FDA does not review compounded medications for safety, effectiveness, or quality before they're marketed. That's the literal meaning: no premarket review, no FDA finding that this product is safe and effective for its use.

What it does not mean

It does not automatically mean "unsafe" or "illegal." Compounding is a lawful, long-standing pharmacy practice; a compounded drug prepared by a licensed pharmacy pursuant to a prescription can be entirely legitimate. "Not approved" is a statement about a regulatory process the product didn't undergo, not a verdict that it's dangerous. It also doesn't mean the product is a "generic" — a generic is an approved product shown equivalent to a brand, which a compounded drug is not.

Why the distinction is real, not a scare word

The phrase matters because premarket review provides assurances a compounded product doesn't have: that the manufacturing is consistent and inspected, that the specific formulation was tested for safety and effectiveness, and that clinical-trial results apply to the exact product you're taking. Without approval, those assurances shift to the individual compounding pharmacy's quality and to formulation-specific evidence that often doesn't exist. So "not FDA approved" flags a genuine difference in the evidence and oversight behind the product — which is why it belongs on the page — without being an accusation.

"Not FDA approved" — meaning vs misreading
It meansIt doesn't mean
No premarket review of this productAutomatically unsafe
Not tested/approved for safety & effectivenessIllegal
Not a generic of an approved productIdentical to the brand product
Trial evidence may not transferGuaranteed not to work

Primary sources

This article's regulatory and safety statements draw on the following primary sources from the U.S. Food and Drug Administration:

Frequently asked questions

Does "not FDA approved" mean the medication is unsafe?

No. It means the product didn't undergo FDA's premarket review of manufacturing, safety, and effectiveness — a statement about process, not a verdict of danger. Compounding is lawful, and a product from a licensed pharmacy can be legitimate. It does mean certain assurances that approval provides are absent, which is a real difference worth understanding.

Is a compounded GLP-1 a generic version?

No. A generic is an FDA-approved product demonstrated equivalent to a brand-name drug. A compounded medication isn't approved and isn't a generic — it's a pharmacy-prepared version that hasn't been through that equivalence process. Calling it a generic would misstate its regulatory status.

Why is the phrase on every page?

Because it flags a genuine difference in the evidence and oversight behind compounded products, and because accurate disclosure is a marker of a legitimate provider. It's not a scare word; it's an honest statement that the product lacks premarket review, which changes what you can assume about it.


Evidence status. Pricing figures are provider-reported or independently calculated as of 2026-07-20, not checkout-verified. Compounded medications are not FDA approved. This article is consumer education, not medical advice. See the methodology for how figures are gated and the public evidence ledger for per-figure sources. Found an error? Use the corrections route.